CSA Medical, Inc.

CSA Medical, Inc. develops and manufactures proprietary interventional liquid nitrogen spray cryotherapy systems that utilize software-driven dosimetry and specialty catheters that enable bronchoscopic delivery of cryogen spray inside the airways to flash freeze and destroy the damaged cells associated with chronic bronchitis and allow for a rejuvenative pattern of healing. The RejuvenAir System is approved in the EU and under clinical investigation in the United States. To learn more about our technology or SPRAYCB clinical trial, please visit www.rejuvenair.com  or  www.clinicaltrials.gov    [Identifiers: NCT03893370]  The SPRAYCB trial is actively recruiting at 25 sites in the U.S.